FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Susan Burchill

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Physiology

Cell Death

Concepts & Ideas

Living Beings

Infants

Co-author Network

Publications

TOP 3
E A Roundhill; Susan A Burchill
Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria.
Virginie F Viprey; Maria V Corrias; Susan A Burchill
Identification of reference microRNAs and suitability of archived hemopoietic samples for robust microRNA expression profiling.
Danielle G Smith; Tapiwanashe Magwere; Susan A Burchill
Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Susan Burchill (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: E A Roundhill; Susan A Burchill
Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria.
British journal of cancer 2012;106(6):1224-33.
2012: Virginie F Viprey; Maria V Corrias; Susan A Burchill
Identification of reference microRNAs and suitability of archived hemopoietic samples for robust microRNA expression profiling.
Analytical biochemistry 2012;421(2):566-72.
2011: Danielle G Smith; Tapiwanashe Magwere; Susan A Burchill
Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors.
Expert review of anticancer therapy 2011;11(2):229-49.
2010: D E White; Susan A Burchill
Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours.
British journal of cancer 2010;103(9):1380-90.
2009: Lydia R Coulthard; Danielle E White; Dominic L Jones; Michael F McDermott; Susan A Burchill
p38(MAPK): stress responses from molecular mechanisms to therapeutics.
Trends in molecular medicine 2009;15(8):369-79.
2009: Andrew Proctor; Samantha C Brownhill; Susan A Burchill
The promise of telomere length, telomerase activity and its regulation in the translocation-dependent cancer ESFT; clinical challenges and utility.
Biochimica et biophysica acta 2009;1792(4):260-74.
2009: Surita Dalal; Susan A Burchill
Preclinical evaluation of vascular-disrupting agents in Ewing's sarcoma family of tumours.
European journal of cancer (Oxford, England : 1990) 2009;45(4):713-22.
2008: Susan A Burchill
Molecular abnormalities in Ewing's sarcoma.
Expert review of anticancer therapy 2008;8(10):1675-87.
2008: Tapiwanashe Magwere; Stephen S Myatt; Susan A Burchill
Manipulation of oxidative stress to induce cell death in Ewing's sarcoma family of tumours.
European journal of cancer (Oxford, England : 1990) 2008;44(15):2276-87.
2008: Danielle E White; Susan A Burchill
BAY 11-7082 induces cell death through NF-kappaB-independent mechanisms in the Ewing's sarcoma family of tumours.
Cancer letters 2008;268(2):212-24.
2008: Paul Roberts; Susan A Burchill; Samantha Brownhill; Catherine Cullinane; Colin Johnston; Mike J Griffiths; Dom J McMullan; Nick Bown; Stephen P Morris; Ian J Lewis
Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: a study by the United Kingdom Cancer Cytogenetics and the Children's Cancer and Leukaemia Group.
Genes, chromosomes & cancer 2008;47(3):207-20.
2008: S S Myatt; Susan A Burchill
The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity.
Oncogene 2008;27(7):985-96.
2007: M Łastowska; Virginie F Viprey; Mauro Santibanez-Koref; Ilka Wappler; Heiko Peters; Catherine Cullinane; Paul Roberts; Andrew G Hall; Deborah A Tweddle; Andrew D J Pearson; Ian Lewis; Susan A Burchill; Michael S Jackson
Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.
Oncogene 2007;26(53):7432-44.
2007: S C Brownhill; C Taylor; Susan A Burchill
Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT.
British journal of cancer 2007;96(12):1914-23.
2007: Virginie F Viprey; Maria V Corrias; Bertil Kagedal; Silvestre Oltra; Katrien Swerts; ales Vicha; Ruth Ladenstein; Susan A Burchill
Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: quality assurance on behalf of SIOPEN-R-NET.
European journal of cancer (Oxford, England : 1990) 2007;43(2):341-50.
2006: Susan A Burchill
What do, can and should we learn from models to evaluate potential anticancer agents?
Future oncology (London, England) 2006;2(2):201-11.
2005: Klaus Beiske; Peter F Ambros; Susan A Burchill; Irene Y Cheung; Katrien Swerts
Detecting minimal residual disease in neuroblastoma patients-the present state of the art.
Cancer letters 2005;228(1-2):229-40.
2005: Stephen S Myatt; Christopher P F Redfern; Susan A Burchill
p38MAPK-Dependent sensitivity of Ewing's sarcoma family of tumors to fenretinide-induced cell death.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):3136-48.
2005: Surita Dalal; Andrea M Berry; Catherine Cullinane; D Charles Mangham; Robert Grimer; Ian J Lewis; Colin Johnston; Valerie Laurence; Susan A Burchill
Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing's sarcoma family.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2364-78.
2004: Kinnari Patel; Peter J Whelan; Stephen Prescott; Samantha C Brownhill; Colin F Johnston; Peter J Selby; Susan A Burchill
The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7511-9.
2004: Andrew J K Williamson; Benjamin C Dibling; James R Boyne; Peter Selby; Susan A Burchill
Basic fibroblast growth factor-induced cell death is effected through sustained activation of p38MAPK and up-regulation of the death receptor p75NTR.
The Journal of biological chemistry 2004;279(46):47912-28.
2004: Richard D Riley; David Heney; David R Jones; Alex J Sutton; Paul C Lambert; Keith Abrams; Bridget Young; Allan Wailoo; Susan A Burchill
A systematic review of molecular and biological tumor markers in neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):4-12.
2004: Susan A Burchill
Micrometastases in neuroblastoma: are they clinically important?
Journal of clinical pathology 2004;57(1):14-20.
2003: Susan A Burchill; Susan Picton; John Wheeldon; Sally E Kinsey; Linda Lashford; Ian Lewis
Reduced tumor load in peripheral blood after treatment with G-CSF and chemotherapy in children with tumors of the Ewing sarcoma family but not neuroblastoma.
Blood 2003;102(9):3459-60.
2003: L-M Sturla; A E Merrick; Susan A Burchill
FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells.
British journal of cancer 2003;89(7):1276-84.
2003: Richard D Riley; Keith Abrams; Alex J Sutton; Paul C Lambert; David R Jones; David Heney; Susan A Burchill
Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future.
British journal of cancer 2003;88(8):1191-8.
2003: Susan A Burchill
Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities.
Journal of clinical pathology 2003;56(2):96-102.
2003: Richard D Riley; Susan A Burchill; Keith Abrams; David Heney; Paul C Lambert; David R Jones; Alex J Sutton; Bridget Young; Allan Wailoo; Ian J Lewis
A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma.
Health technology assessment (Winchester, England) 2003;7(5):1-162.
2003: Richard D Riley; Susan A Burchill; Keith Abrams; David Heney; Alex J Sutton; David R Jones; Paul C Lambert; Bridget Young; Allan Wailoo; Ian J Lewis
A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family.
European journal of cancer (Oxford, England : 1990) 2003;39(1):19-30.
2003: Maria P Michelagnoli; Susan A Burchill; Catherine Cullinane; Peter J Selby; Ian J Lewis
Myogenin--a more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1.
Medical and pediatric oncology 2003;40(1):1-8.
2002: Paul Berry; Susan A Burchill
Endothelins may modulate invasion and proliferation of Ewing's sarcoma and neuroblastoma.
Clinical science (London, England : 1979) 2002;103 Suppl 48():322S-326S.
2002: Susan A Burchill; Georgina Westwood
Mechanism of basic fibroblast growth factor-induced cell death.
Apoptosis : an international journal on programmed cell death 2002;7(1):5-12.
2002: Georgina Westwood; Benjamin C Dibling; Darren Cuthbert-Heavens; Susan A Burchill
Basic fibroblast growth factor (bFGF)-induced cell death is mediated through a caspase-dependent and p53-independent cell death receptor pathway.
Oncogene 2002;21(5):809-24.
2001: S Y Tan; Susan A Burchill; S C Brownhill; M P Gerrard; A Watmore; B E Wagner; S Variend
Small round cell tumor with biphenotypic differentiation and variant of t(21;22)(q22;q12).
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2001;4(4):391-6.
2001: Susan A Burchill; Ian J Lewis; Keith Abrams; R Riley; John Imeson; Andrew D J Pearson; Ross Pinkerton; Peter Selby
Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1795-801.
2001: Susan A Burchill; Sally E Kinsey; Susan Picton; P Roberts; C Ross Pinkerton; Peter Selby; Ian J Lewis
Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma.
Medical and pediatric oncology 2001;36(1):213-9.
2001: PA Berry; Y F Zhang; N D Carter; S Jeffery; Susan A Burchill
Decreased wild-type full-length Et-A and -B receptors in neuroblastoma and Ewing sarcoma cells.
Medical and pediatric oncology 2001;36(1):142-6.
2000: L M Sturla; Georgina Westwood; P J Selby; Ian J Lewis; Susan A Burchill
Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
Cancer research 2000;60(21):6160-70.
2000: Susan A Burchill; P J Selby
Molecular detection of low-level disease in patients with cancer.
The Journal of pathology 2000;190(1):6-14.
1999: Susan A Burchill; Ian J Lewis; Peter Selby
Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells.
British journal of cancer 1999;79(5-6):971-7.
1999: P Roberts; Susan A Burchill; R A Beddow; J Wheeldon; Catherine Cullinane; Ian J Lewis
A combined cytogenetic and molecular approach to diagnosis in a case of desmoplastic small round cell tumor with a complex translocation (11;22;21).
Cancer genetics and cytogenetics 1999;108(1):19-25.
1998: Y F Zhang; S Jeffery; Susan A Burchill; PA Berry; JUAN-CARLOS KASKI; N D Carter
Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma.
British journal of cancer 1998;78(9):1141-6.
1998: david wyld; Peter Selby; T J Perren; S K Jonas; Timothy G Allen-Mersh; J Wheeldon; Susan A Burchill
Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20.
International journal of cancer. Journal international du cancer 1998;79(3):288-93.
1998: Susan A Burchill; PA Berry; F M Bradbury; Ian J Lewis
Contrasting levels of p21ras activation and expression of neurofibromin in peripheral primitive neuroectodermal tumour and neuroblastoma cells, and their response to retinoic acid.
Journal of the neurological sciences 1998;157(2):129-37.
1997: Susan A Burchill; J Wheeldon; Catherine Cullinane; Ian J Lewis
EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(2):239-43.
1996: Ken Pittman; Susan A Burchill; B Smith; Jennifer Southgate; Johnathan Keith Joffe; M Gore; Peter Selby
Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(3):297-301.
1995: Susan A Burchill; P A Berry; Ian J Lewis
Activation of p21ras by nerve growth factor in neuroblastoma cells.
Journal of the neurological sciences 1995;133(1-2):3-10.
1995: Susan A Burchill; M F Bradbury; Ken Pittman; Jennifer Southgate; B Smith; Peter Selby
Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.
British journal of cancer 1995;71(2):278-81.
1995: Susan A Burchill; F M Bradbury; Peter Selby; Ian J Lewis
Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA.
European journal of cancer (Oxford, England : 1990) 1995;31A(4):553-6.
1995: Susan A Burchill; P A Berry; Ian J Lewis
Effect of retinoic acid on p21ras and regulators of its activity in neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1995;31A(4):476-81.
1994: Susan A Burchill; P A Berry; Ian J Lewis
Changing expression of GTPase activating proteins with differentiation in neuroblastoma.
Journal of the neurological sciences 1994;126(2):126-32.
1994: Susan A Burchill; F M Bradbury; B Smith; Ian J Lewis; Peter Selby
Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA.
International journal of cancer. Journal international du cancer 1994;57(5):671-5.